As expected, western blotting analysis and immunolabeling with anti-GFAP antibody, revealed an increased expression of GFAP (Figure 9A), and consequent gliosis (Figure 9B), indicating that, 48 hours after treatment, retinopathy was well established. The gene discussed is GFAP; the disease is retinal disorder.